Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating
On November 18, LifeSci Capital reiterated a Buy rating on Tectonic Therapeutic, Inc. (NASDAQ:TECX) stock with a price target of $88. Tectonic Therapeutic, Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Braidwell LP Alex Karnal | 927,524 | $19,348,151 | +26% | 0.62% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 903,400 | $18,844,924 | +804% | 0.11% |
| 3. | OrbiMed Advisors Samuel Isaly | 574,600 | $11,986,156 | 0.24% | |
| 4. | Point72 Asset Management Steve Cohen | 492,332 | $10,270,046 | +17% | 0.01% |
| 5. | Vestal Point Capital Ryan Wilder | 328,000 | $6,842,080 | 0.23% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.10 | 2,500 | $52,750.00 | 127,030 | 2026-02-11 | Filing | |
| $21.10 | 2,500 | $52,750.00 | 237,547 | 2026-02-11 | Filing | |
| $21.61 | 6,000 | $129,660.00 | 32,044 | 2026-02-10 | Filing | |
| $16.31 | 53,706 | $875,944.86 | 1,503,358 | 2025-04-11 | Filing | |
| $16.73 | 45,858 | $767,204.34 | 1,449,652 | 2025-04-10 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.00 | 1,065 | $31,950.00 | 67,682 | 2026-05-04 | Filing | |
| $31.05 | 1,000 | $31,050.00 | 68,747 | 2026-04-01 | Filing | |
| $30.00 | 10,000 | $300,000.00 | 69,747 | 2026-03-06 | Filing | |
| $35.00 | 215 | $7,525.00 | 55,285 | 2026-03-06 | Filing | |
| $30.00 | 6,047 | $181,410.00 | 55,500 | 2026-03-06 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,141,824 | $35,293,780 | 0.06% | |
| 2. | 473,532 | $14,636,874 | 0% | |
| 3. | 67,895 | $2,098,634 | 0% | |
| 4. | 63,607 | $1,966,092 | 0% | |
| 5. | 37,184 | $1,149,357 | 0.88% |